Kristian Helin is the Chief Executive and President of The Institute of Cancer Research, London, having started in September 2021. Based in United Kingdom.
Kristian Helin is the Chief Executive and President of The Institute of Cancer Research, London, having started in September 2021. He obtained his MSc in Chemical Engineering from the Technical University of Denmark and a PhD from the University of Copenhagen. His prior background includes research fellowships at Massachusetts General Hospital and Harvard Medical School, and leadership roles at the Danish Cancer Society, the European Institute of Oncology, and the Biotech Research and Innovation Centre (BRIC). His work in epigenetics and cancer also led to the establishment of the biotech company EpiTherapeutics, which was sold to Gilead Inc. in 2015.
Full founder directory · Investor directory · Company funding database · Fundraising library